School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Tremona Road, Southampton SO16 6YD, UK.
National Institute for Health and Care Research Applied Research Collaboration Wessex, Southampton Science Park, Innovation Centre, 2 Venture Road, Chilworth, Southampton SO16 7NP, UK.
Alcohol Alcohol. 2024 Sep 21;59(6). doi: 10.1093/alcalc/agae069.
To explore the views and attitudes of professionals, patients and the public to a role for community pharmacists in the identification of alcohol-related liver disease (ArLD).
Semi-structured interviews were conducted with a purposive sample of patients with ArLD, members of the public, pharmacy staff, and clinicians managing patients with ArLD across the Wessex region of south England. The interviews explored experiences of alcohol, ArLD and health advice in pharmacies and elicited views of what a pharmacist role in identifying ArLD could entail and factors influencing this. Transcripts were analysed using reflexive thematic analysis.
Twenty-six participants were interviewed and three themes were generated: (i) acknowledging, seeking help and engaging with a hidden problem; (ii) professional roles, boundaries and attributes; (iii) communication, relationships, collaboration and support. Participants reported key challenges to identifying people at-risk of ArLD. Offering testing for ArLD was perceived to motivate engagement but there were concerns about pharmacists performing this. A role was mostly seen to be finding people at-risk and engaging them with further care such as referral to liver services. This was perceived to require developing interprofessional collaborations, remuneration and training for pharmacy staff, and community-based liver testing.
Professionals, patient and public participants recognized a role for pharmacists in the identification of ArLD. This was envisaged to incorporate educating pharmacy users about ArLD risk, and identifying and directly engaging those at-risk with liver and support services through development of interprofessional collaborations. The findings of this study support and can inform future work to develop this role.
探讨专业人士、患者和公众对社区药剂师在识别酒精相关性肝病（ArLD）中的作用的看法和态度。
采用目的性抽样方法，对英格兰南部 Wessex 地区的 ArLD 患者、公众、药房工作人员和管理 ArLD 患者的临床医生进行了半结构化访谈。访谈内容包括在药房中与酒精、ArLD 和健康建议相关的经验，以及对药剂师在识别 ArLD 中可能承担的角色和影响因素的看法。使用反思性主题分析对转录本进行分析。
共访谈了 26 名参与者，产生了三个主题：（i）承认、寻求帮助和处理隐藏问题；（ii）专业角色、界限和属性；（iii）沟通、关系、协作和支持。参与者报告了识别 ArLD 风险人群的主要挑战。提供 ArLD 检测被认为可以激发参与，但有人担心药剂师进行此项检测。大多数人认为药剂师的角色是发现有风险的人，并将他们与进一步的护理（如转介到肝脏服务）联系起来。这被认为需要发展跨专业合作、为药房工作人员提供报酬和培训，以及开展基于社区的肝脏检测。
专业人士、患者和公众参与者都认识到药剂师在识别 ArLD 中的作用。这包括教育药房用户有关 ArLD 风险的知识，以及通过发展跨专业合作，直接与有风险的患者和支持服务联系起来。本研究的结果支持并为未来发展这一角色提供了信息。
